Advertisement
U.S. markets closed
Advertisement

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
24.50+1.17 (+5.02%)
At close: 04:00PM EST
24.37 -0.13 (-0.53%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close23.33
Open23.38
Bid9.85 x 900
Ask25.25 x 800
Day's Range22.88 - 24.54
52 Week Range15.44 - 35.60
Volume1,492,159
Avg. Volume2,518,326
Market Cap4.013B
Beta (5Y Monthly)1.47
PE Ratio (TTM)N/A
EPS (TTM)-3.26
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est33.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RVMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Revolution Medicines, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/09/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • Simply Wall St.

    A great week that adds to Revolution Medicines, Inc.'s (NASDAQ:RVMD) one-year returns, institutional investors who own 74% must be happy

    Key Insights Given the large stake in the stock by institutions, Revolution Medicines' stock price might be vulnerable...

  • InvestorPlace

    3 Biotech Stocks That Could Boom or Bust by 2025

    InvestorPlace published an article last December about the seven hottest biotech stocks to own in 2023 and beyond. One of the seven was the SPDR S&P Biotech ETF (NYSEARCA:XBI). XBI tracks the performance of the S&P Biotechnology Select Industry Index which represents the biotechnology sub-sector of the S&P Total Market Index. XBI currently has 133 holdings. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. The index and exchange-traded fund ETF are rebala

  • GlobeNewswire

    Revolution Medicines Completes Acquisition of EQRx

    Acquisition Expected to Add Approximately $1.1 Billion in Net Cash to Revolution Medicines’ Balance Sheet, Supporting Late-Stage Development of RAS(ON) Inhibitor Investigational Drugs Sandra Horning, M.D., Joins Revolution Medicines' Board of Directors REDWOOD CITY, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced it has closed its acquisition of EQRx, Inc